PLC
ASMB icon

Peapod Lane Capital’s Assembly Biosciences ASMB Stock Holding History

Peapod Lane Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-62,970
Closed -$994K – 63
2024
Q4 		$994K Buy
+62,970
New +$1.01M 0.98% 44

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $432M AUM 20.27% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Peapod Lane Capital's ASMB Position: Q1 2025 in Review

Peapod Lane Capital sold out of Assembly Biosciences (ASMB) in Q1 2025, closing a stake of 62,970 shares — an estimated $994K sold.

Peapod Lane Capital first reported a position in ASMB in Q4 2024 and held it in 1 quarter. The position peaked at $994K in Q4 2024. 37 funds tracked by Wall St. Rank hold ASMB as of Q1 2025.

  • Peapod Lane Capital reported no remaining Assembly Biosciences position as of Q1 2025 after selling out during the quarter.
  • Peapod Lane Capital sold 62,970 Assembly Biosciences shares in Q1 2025, an estimated $994K.
  • Peapod Lane Capital first reported a position in Assembly Biosciences in Q4 2024 and held it in 1 quarter.
  • Peapod Lane Capital's Assembly Biosciences position peaked at $994K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2025.

Based on Peapod Lane Capital's 13F filing for Q1 2025, filed 30 Apr 2025.